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A group of experts on lower urinary tract dysfunction and cystitis met together to make a consensus
report on the assessment of ketamine uropathy (KU) which encompasses ketamine cystitis.
Essential tests, which should be performed in all KU patients, are (1) detailed history taking with
structured questionnaire, (2) physical examination, (3) urine tests including test strip biochemistry and
sediments analysis, urine culture, and cytology, (4) blood tests including complete blood cell counts with
differential counts, liver and renal function tests, IgE, HIV, VDRL, (5) urological tests including uro-
ﬂowmetry and post void residual urine volume and renosonography.
Optional tests, which will be performed in selective cases, are (1) bladder diary for 48-72 hours, (2)
bladder wall thickness by ultrasound, (3) upper tract evaluation with excretory urography, computed
tomography of abdomen, diuretic renal scan, (4) lower urinary tract evaluation with cystoscopy, voiding
cystography, urodynamics or videourodynamics, (5) bladder and/or ureteral biopsy, (6) abdominal echo
and/or gastroendoscope. Optional tests are usually indicated when essential tests disclose abnormal
ﬁndings.
Using the standardized tools to assess patients with ketamine abuse, patients characteristics can be
clariﬁed and different therapeutic strategies for ketamine uropathy can be compared in the future.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
As ketamine uropathy (KU) is a relatively new clinical entity
since 2007,1,2 there is no consensus about the assessment and
evaluation for KU to date. Recent publications show that urinary
bladder, ureter, and kidney may be damaged in the patients with
chronic use of ketamine.3,4 In addition, brain, liver, upper gastro-
intestinal tract, and genital tract functions may be also involved.5e7zu Chi Hospital, 289,
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Table 1
Essential tests for ketamine-associated uropathy.
History taking Structured questionnaire including illicit drug use
history, LUTS, pain score, sexual function, mood and
quality of life.
Physical
examination
Height, weight, and blood pressure. Nostril, and
genital skin.
Urine tests Urine routine, culture, cytology.
Blood tests BUN/Cr; GOT/GPT, bilirubin, IgE, CBC with
differential counts, HIV, VDRL
Urological
examinations
Uroﬂowmetry, PVR and renosonography
LUTS ¼ lower urinary tract symptoms; PVR ¼ post-void residual urine volume.
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symptoms with interstitial cystitis (IC), recommendations of the
assessment for IC patients is adopted for KU. Contracted bladder is
present in many cases of KU, part of the concept of neurogenic
bladder is adopted. In addition, hydronephrosis and ureteral stric-
ture are encountered in severe cases of KU, upper urinary tract
evaluation should be performed. Patients also suffer from hep-
atobiliary problems, epigastralgia, sexual dysfunction, brain
dysfunction. Further assessments are mandatory if the patients
have symptoms or dysfunction.
2. Essential tests for ketamine uropathy
Table 1 summarizes essential tests for KU. A structured ques-
tionnaire is developed to assist history taking (Appendix). Patients
should be queried about ketamine use history, including duration,
frequency, dosage, and route of ketamine abuse. Whether the pa-
tient is an active abuser or ex-abuser should be clariﬁed. The
duration of ketamine cessation must be documented for an ex-
abuser. Other illicit drugs addiction, smoking, betel nut chewing,
and alcohol drinking history should also be asked. Up to date, there
is no evidence in the relationship between betel nut chewing his-
tory and ketamine uropathy. Since this questionnaire is adopted
from the case report form of Taiwan Food and Drug Administration
(TFDA), we continue to use this item. In this way, we can compare
our data with those already registered on TFDA. Hopefully, the
relationship between betel nut chewing, a common behavior in
Taiwan, can be illustrated later. The interval between the beginning
of ketamine abuse and the occurrence of lower urinary tract
symptoms (LUTS) should be noted. The severity of LUTS could be
assessed by International Prostate Symptoms Score and the
“O'Leary-Sant Symptom and Problem Questionnaire”.9 “Pelvic Pain
and Urgency/Frequency (PUF) Questionnaire” has been validated
for the evaluation of KU in Hong Kong and was shown to correlate
well with cystoscopic change, urodynamic abnormalities, and
hydronephrosis in patients with KU.10 Since PUF was not familiar to
most Taiwanese doctors and many experts already used Interna-
tional Prostate Symptoms Score (IPSS) and O'Leary-Sant Symptom
and Problem questionnaire, which will be continuously recom-
mended in Taiwan. Mood of the patients should be assessed
because KU patients may have suicide idea and attempts. A simple
tool is provided in the structured questionnaire. Sexual dysfunction
has been reported in female ketamine-abusers,5 and male patientsTable 2
Optional tests for ketamine-associated uropathy
Functional bladder capacity/maximal voided volume Bladder diary for 4
Bladder ﬁbrosis Transabdominal u
Upper urinary tract evaluation Excretory urograp
Lower urinary tract evaluation Cystoscopy, voidin
Histology Bladder and/or ure
Gastrointestinal tract Abdominal echo amay share similar symptoms. Erectile dysfunction should be asked
in men, while problems of sexual arousal, lubrication, orgasm, and
dyspareunia should be evaluated in women.
Though most physical examination will be normal, special
attention should focus on the nose to see if there is residual white
substance around nostril, which may be a sign of continuing use of
ketamine. Basic physical examination, including pelvic examina-
tion should be performed to exclude other disorders with similar
clinical symptoms. Vaginitis, urethritis, prostatitis, urethral diver-
ticulum, and other potential etiology of pain or infection should be
excluded through the evaluation. Genital skin lesions should be
recorded for the risk for associated sexually transmitted disease.
Urinalysis is amandatory examination for KUpatients, and urine
culture should be performed for those with pyuria. For patients
with hematuria, urine cytology should be collected to exclude
urothelial carcinoma. Renal and liver function test should be
checked for all patients to rule out potential renal and hepatic
damages. Complete blood-cell count with differential count is or-
dered to check the presence of eosinophilia and possible anemia.
Immunoglobulin E should be checked to rule to allergic reaction.
Patients with ketamine cystitis had higher serum IgE than patients
with interstitial cystitis/bladder pain syndrome or acute bacterial
cystitis, or controls. Serum IgE and the severity of eosinophil inﬁl-
tration associated with bladder pain severity and small maximal
bladder capacity.8 HIV and VDRL should be checked to rule out
coexisted sexually transmitted diseases such as acquired immu-
nodeﬁciency disease and syphilis.
Uroﬂowmetry and post-void residual urine (PVR) should be
performed. Voided volume plus PVR can be used as a surrogate of
bladder capacity which is an important parameter in managing KU.
Renosonography should be performed to rule out hydronephrosis.
The grade of hydronephrosis must be documented once it was
identiﬁed.11
3. Optional tests for ketamine uropathy
Table 2 lists the optional tests for KU. A voiding diary can be
recorded for 48e72 hours in cooperative patients. Maximal voided
volume can be a good surrogate of functional bladder capacity since
most of the KU patients have low PVR. However, many patients are
uncooperative in recording voiding diary. Bladder sonography can
be performed to measure bladder wall thickness which may sug-
gest the presence of bladder ﬁbrosis. However, the technical difﬁ-
culty in measuring bladder wall thickness in a ﬁxed bladder volume
makes this test not easy for the KU patients.
Upper urinary tract evaluation such as intravenous urography or
computed tomography should be arranged in the presence of
hydronephrosis on renosongraphy.11 Grade and side of hydro-
nephrosis/ureteral stricture should be recorded. Voiding cystour-
ethrography could be performed once vesico-ureteral reﬂux was
suspected as the etiology of hydronephrosis. Since this is an inva-
sive procedure and may cause severe pain, adequate anesthesia
and/or pain killer should be provided.
Lower urinary tract can be assessed by a variety of tools.
Cystoscopy is not necessary to reach the diagnosis of KU in all pa-
tients. The cystoscopic ﬁndings of KU patients are non-speciﬁc and8e72 hours in cooperative patients.
ltrasound measuring bladder wall thickness at 1/2-2/3 expected bladder capacity
hy, CT of abdomen (Non-contrast CT if impaired renal function), diuretic DTPA
g cystography, urodynamics or videourodynamics
teral biopsy
nd/or gastroendoscope for epigastralgia and abnormal liver functions.
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be considered when the diagnosis of KU is in doubt. Disorders such
as bladder cancer, bladder stones, urethral diverticula, and intra-
vesical foreign bodies could be identiﬁed by cystoscopy and the
therapeutic approach would then be changed. The role of cystos-
copy in KU may be changed after the ﬁrst report of bladder cancer
in a KU patient.12 Cystoscopy could also be performed in concom-
itance with bladder hydrodilatation under regional or general
anesthesia because many KU patients could not tolerate the pro-
cedure when it is performed under local anesthesia.
Urodynamic study (UDS) is not necessary for the diagnosis of
uncomplicated KU The ﬁndings of UDS are inconsistent and could
not provide further information for diagnosis or guiding therapy.
Furthermore,many patients could not tolerate bladder distension or
urethral catheterization during the examination. UDS should be
considered only when other lower urinary tract dysfunction was
suspected and the treatment would be different once it was iden-
tiﬁed, such as bladder outlet obstruction or detrusor underactivity.
Video-UDS could identify VUR and would be beneﬁcial in differ-
entiating the etiology of hydronephrosis. The potassium sensitivity
test (or KCl test) is not recommended in the evaluation of IC patients,
as it could not provide information for diagnosis and guiding ther-
apy. It is therefore not suggested in KUpatients as the same reasons.
Routine bladder biopsy is an issue to be debated. Generally,
histology shows denuded epithelium and inﬂammation with
eosinophil inﬁltrationwhichmay be speciﬁc. Bladder biopsy should
only be performed when bladder cancer and/or urothelial carci-
noma in situ are suspected, particularly after the publication of the
ﬁrst ketamine abuse associated bladder tumors was reported in
2014.12
Abdominal ultrasonography can be performed in the patients
complaining abdominal pain or elevated liver enzymes. Dilatation
of bile ducts is quite common. Without knowing the history of
ketamine abuse, incision of Sphincter of Oddi had been performed
without signiﬁcant beneﬁts.7 Panendoscopy may be performed in
cases with frequent epigastralgia, though negative ﬁndings were
usually reported.
4. Conclusions
We recommend essential and options tests to assess patients
with ketamine abuse. Hopefully, patient characteristics can be
clariﬁed and different therapeutic strategies for ketamine uropathy
can be compared in the future. Then we can have a treatment al-
gorithm for ketamine uropathy soon!Conﬂicts of interest
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